Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Cancer

Liver cancer
October 8, 2020/Cancer/Tumor Oncology

FDA Approves New Treatment Regime for Advanced Liver Cancer

IMbrave-150 changes standard of care

20-NEU-1975326_sex differences in glioblastoma_650x450

Studies of Sex-Related Molecular Differences in Glioblastoma Draw $10.4M in NIH Support

Funding expands work by consortium led by Cleveland Clinic Lerner Research Institute and CWRU

Spine cancer
October 1, 2020/Cancer

Spine Stereotactic Radiosurgery Outcomes Among Adolescents and Young Adults With Metastatic Ewing Sarcoma and Osteosarcoma

Young patients with spinal tumors could be good candidates for radiosurgery, study suggests

650×450-Severe-hearing-loss-in-childhood-cancer-survivors
September 28, 2020/Cancer

Neurocognitive Deficits Prevalent in Patients With Hearing Loss Caused by Cancer Treatment

More study needed on role of sodium thiosulfate in preventing ototoxicity

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-Open-Partial-Nephrectomy
September 28, 2020/Cancer

Alternatives to Partial Nephrectomy in Patients With Severe Chronic Kidney Disease

Patient selection is key

Rabi Hanna, MD
September 17, 2020/Cancer

Individualizing Therapy for Cancer Patients With Autism Spectrum Disorder

Simple adjustments can make a significant difference

Nathan Pennell, MD
September 17, 2020/Cancer/Tumor Oncology

A New Option for Patients with RET Fusion-Positive NSCLC Demonstrates Safety and Efficacy

Selpercatinib beats others in ORR, PFS, safety

Pink ribbon
September 15, 2020/Cancer

How COVID-19 Changed Breast Cancer Care

Managing the pandemic's impact on cancer patients

650×450-SARS-CoV-2-20-AND-1915132
September 14, 2020/Cancer

Is There a Link Between Prostate Cancer and COVID-19?

Cleveland Clinic researchers explore enterprise-wide testing registry to investigate

19-DDI-238-Polyps-CQD-Hero
September 14, 2020/Cancer

Phase 3 Study Tests Sulindac/Eflornithine Combination for Familial Adenomatous Polyposis

Two-drug therapy reduces progression in rare hereditary cancer syndrome

BackPage 50 of 87Next

Advertisement

Ad